Clinical Trial Update: This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update describes an early Phase 1 exploratory study to assess tolerability and safety of GC012F in patients with multiple sclerosis, current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• GC012F

Snippet

Sponsor: Daishi Tian | Conditions: Multiple Sclerosis | EARLY_Phase 1 | Status: RECRUITING